Landscapes / Targets
IL-36R
3 drugs act on IL-36R, in 6 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs3
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Spesolimabnot checked |
Monoclonal antibody |
LEO Pharma +1 · Private |
Approved | 30 Sep 2027Phase 2 trial completes | |
| How it works | An antibody | ||||
| Next date | 30 Sep 2027 · Phase 2 trial completes | ||||
| Also tested for | Generalized Pustular Psoriasis, Pyoderma Gangrenosum | ||||
| Open drug page | |||||
— |
Huahai Pharmaceutical (Huaota) · Public 600521.SS |
Phase 2 | — | ||
| Also tested for | Generalized Pustular Psoriasis (GPP) | ||||
| Open drug page | |||||
— |
Huahai Pharmaceutical (Huaota) · Public 600521.SS |
Phase 1/2 | — | ||
| Also tested for | Hidradenitis Suppurativa, Acne Vulgaris | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 2 of 3 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026